Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1405

1.

Danon disease for the cardiologist: case report and review of the literature.

D'souza RS, Mestroni L, Taylor MRG.

J Community Hosp Intern Med Perspect. 2017 Jun 6;7(2):107-114. doi: 10.1080/20009666.2017.1324239. eCollection 2017 Mar.

2.

Holter-monitored sudden cardiac arrest after atrioventricular junction ablation.

Waldmann V, Marijon E, Combes N.

Pacing Clin Electrophysiol. 2017 Jun 15. doi: 10.1111/pace.13140. [Epub ahead of print]

PMID:
28617967
3.

Atrial fibrillation following synthetic cannabinoid abuse.

Efe TH, Felekoglu MA, Çimen T, Doğan M.

Turk Kardiyol Dern Ars. 2017 Jun;45(4):362-364. doi: 10.5543/tkda.2016.70367.

4.

Management of an asymptomatic patient with the apical variant of hypertrophic cardiomyopathy.

Trojan MKB, Biederman RW.

Echocardiography. 2017 May 30. doi: 10.1111/echo.13567. [Epub ahead of print]

PMID:
28560795
5.

Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - A systematic review and dose-response meta-analysis of prospective studies.

Aune D, Sen A, ó'Hartaigh B, Janszky I, Romundstad PR, Tonstad S, Vatten LJ.

Nutr Metab Cardiovasc Dis. 2017 Jun;27(6):504-517. doi: 10.1016/j.numecd.2017.04.004. Epub 2017 Apr 21.

PMID:
28552551
6.

Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation: Results from the Chinese AF registry.

Wu S, Yang YM, Zhu J, Ren JM, Wang J, Zhang H, Shao XH.

Am J Emerg Med. 2017 Apr 27. pii: S0735-6757(17)30334-0. doi: 10.1016/j.ajem.2017.04.070. [Epub ahead of print]

PMID:
28551087
7.

Arrhythmia burden and related outcomes in Eisenmenger syndrome.

Baskar S, Horne P, Fitzsimmons S, Khoury PR, Vettukattill J, Niwa K, Agaki T, Spence M, Sakazaki H, Veldtman G.

Congenit Heart Dis. 2017 May 19. doi: 10.1111/chd.12481. [Epub ahead of print]

PMID:
28523857
8.

Effectiveness of enzyme replacement therapy in Fabry disease: Long term experience in Argentina.

Cabrera G, Politei J, Antongiovani N, Amartino H; GADYTEF (Grupo Argentino de Diagnóstico y Tratamiento de la Enfermedad de Fabry).

Mol Genet Metab Rep. 2017 May 4;11:65-68. doi: 10.1016/j.ymgmr.2017.02.005. eCollection 2017 Jun.

9.

Amiodarone-Induced Third Degree Atrioventricular Block and Extreme QT Prolongation Generating Torsade Des Pointes in Paroxysmal Atrial Fibrillation.

Sequeira OR, Aquino NJ, Gómez NB, García LB, Cáceres C, Lovera OA, Centurión OA.

J Atr Fibrillation. 2016 Oct 31;9(3):1502. doi: 10.4022/jafib.1502. eCollection 2016 Oct-Nov.

10.

Atrial fibrillation associated with Wolff-Parkinson-White syndrome in a patient with concomitant Brugada syndrome.

Shi S, Liu T, Barajas-Martinez H, Pfeiffer R, Jiang H, Huang C, Hu D.

HeartRhythm Case Rep. 2017 Jan 3;3(1):13-17. doi: 10.1016/j.hrcr.2016.12.001. eCollection 2017 Jan. No abstract available.

11.

Sleep-Disordered Breathing and Arrhythmia in Heart Failure Patients.

Fox H, Bitter T, Horstkotte D, Oldenburg O.

Sleep Med Clin. 2017 Jun;12(2):229-241. doi: 10.1016/j.jsmc.2017.01.003. Epub 2017 Mar 9. Review.

PMID:
28477777
12.

The future of atrial fibrillation management: integrated care and stratified therapy.

Kirchhof P.

Lancet. 2017 Apr 28. pii: S0140-6736(17)31072-3. doi: 10.1016/S0140-6736(17)31072-3. [Epub ahead of print] Review.

PMID:
28460828
13.

Ebstein Anomaly.

Sherwin ED, Abrams DJ.

Card Electrophysiol Clin. 2017 Jun;9(2):245-254. doi: 10.1016/j.ccep.2017.02.007. Review.

PMID:
28457239
14.

Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative.

Coiro S, Girerd N, Rossignol P, Bauersachs J, Pitt B, Fay R, Ambrosio G, Solomon SD, Dickstein K, Zannad F.

Clin Res Cardiol. 2017 Apr 28. doi: 10.1007/s00392-017-1116-z. [Epub ahead of print]

PMID:
28455597
15.

Prevalence of malignant arrhythmia and sudden cardiac death in takotsubo syndrome and its management.

El-Battrawy I, Lang S, Ansari U, Tülümen E, Schramm K, Fastner C, Zhou X, Hoffmann U, Borggrefe M, Akin I.

Europace. 2017 Apr 26. doi: 10.1093/europace/eux073. [Epub ahead of print]

PMID:
28453621
16.

Mechanical dispersion and global longitudinal strain by speckle tracking echocardiography: Predictors of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy.

Candan O, Gecmen C, Bayam E, Guner A, Celik M, Doğan C.

Echocardiography. 2017 Jun;34(6):835-842. doi: 10.1111/echo.13547. Epub 2017 Apr 26.

PMID:
28444773
17.

"J waves" induced after short coupling intervals: a manifestations of latent depolarization abnormality?

Aizawa Y, Nakayama M, Sato M, Okabe M, Aizawa Y, Takatsuki S, Fukuda K.

Europace. 2017 Apr 24. doi: 10.1093/europace/eux062. [Epub ahead of print]

PMID:
28444176
18.

Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation - A Nationwide Cohort Study.

Chao TF, Liu CJ, Tuan TC, Chen SJ, Chen TJ, Lip GYH, Chen SA.

Sci Rep. 2017 Apr 19;7:46445. doi: 10.1038/srep46445.

19.

P210Long- term outcome of primary mitral valve prolapse: results from a population of 250 patients referred to a tertiary cardiovascular center.

Mecarocci V, Mori F.

Eur Heart J Cardiovasc Imaging. 2016 Dec 1;17(suppl_2):ii29-ii37. doi: 10.1093/ehjci/jew236.001.

PMID:
28415082
20.

Deleterious protein-altering mutations in the SCN10A voltage-gated sodium channel gene are associated with prolonged QT.

Abou Ziki MD, Seidelmann SB, Smith E, Atteya G, Jiang Y, Fernandes RG, Marieb MA, Akar JG, Mani A.

Clin Genet. 2017 Apr 13. doi: 10.1111/cge.13036. [Epub ahead of print]

PMID:
28407228

Supplemental Content

Loading ...
Support Center